Poinciana Advisors Group LLC Sells 762 Shares of CME Group Inc. (NASDAQ:CME)

Poinciana Advisors Group LLC cut its position in CME Group Inc. (NASDAQ:CME) by 43.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,005 shares of the financial services provider’s stock after selling 762 shares during the quarter. Poinciana Advisors Group LLC’s holdings in CME Group were worth $267,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in CME. Wayfinding Financial LLC purchased a new position in CME Group during the first quarter worth about $25,000. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC grew its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management purchased a new position in CME Group during the first quarter worth about $32,000. Finally, New Age Alpha Advisors LLC grew its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other news, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the transaction, the director directly owned 4,900 shares in the company, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William R. Shepard bought 256 shares of the company’s stock in a transaction on Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director directly owned 258,196 shares of the company’s stock, valued at approximately $69,849,763.88. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 13,400 shares of company stock valued at $3,680,610 over the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.0%

Shares of CME stock opened at $275.64 on Thursday. The business has a 50-day moving average of $276.73 and a 200 day moving average of $258.73. The stock has a market capitalization of $99.33 billion, a PE ratio of 27.73, a P/E/G ratio of 3.74 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.50 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend was Monday, June 9th. CME Group’s payout ratio is 50.30%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, July 5th. Keefe, Bruyette & Woods boosted their target price on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a research report on Thursday, April 24th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. JPMorgan Chase & Co. cut their price objective on CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a report on Thursday, April 24th. Finally, Barclays upped their price objective on CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 23rd. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $259.87.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.